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Introduction
Until recently, pachymetric measurement of central corneal 
thickness (CCT) has been the exclusive territory of corneal 
specialists. It is an important tool to evaluate the health of the 
cornea, measuring its thickness to assessathe capacity to pump 
out excess fl uid and maintain clarity [1, 2].
Corneal specialists and general ophthalmologists 
continue to rely on accurate corneal pachymetry readings to 
manage patients with corneal ectasias (keratoglobus, pellucid 
degeneration, keratoconus, Fuchs’ endothelial dystrophy, 
bullous keratopathy, corneal rejection post - penetrating 
keratoplasty, and other causes of corneal edema).
However, an increasing number of ophthalmologists are now 
obtaining CCT measurements on patients with (or suspected to 
have) glaucoma. Studies about the cornea, show that corneal 
thickness is an important factor in accurately diagnosing 
introcular pressure. The repost summarizing the fi ve-year results 
from of the Ocular Hypertension Study (OHTS) was released in 
2002. The study’s goal was to determine if early intervention 
with pressure lowering medications could reduce the number 
of ocular hypertensive (OHT) patients who develop glaucoma. 
During the study, a critical discovery was made regarding the 
relationship between corneal thickness and its correlаtion with 
intraocular pressure and the glaucomatous  process.
A Thin Cornea - The Danger of Misreading Eye Pressure
Patients with thin corneas (less than 555 μm central corneal 
thickness) show artifi cially low IOP readings. This is dangerous 
because if the actual IOP is higher than the reading shows, the 
patient may be at risk of developing glaucoma. Left untreated, 
high IOP can lead to glaucoma and vision loss. It is important 
that ophthalmologyst have an accurate IOP reading to diagnose 
the risk and decide upon a treatment plan [3-5].
A Thicker Cornea - May Mean Less Reason to Worry About 
Glaucoma
Those patients with thicker CCT may show a higher reading 
of IOP than actually exists. However, it is still important to have 
regular eye exams to monitor eye pressure and stay aware of 
changes.
Pachymetry - A Simple Test to Determine Corneal Thickness
A pachymetry test is a simple, quick, painless test to measure 
the thickness of the cornea. With this measurement, we can 
better etimate the true IOP readin, and develop a treatment plan 
that is right for the condition. Several techniques are available 
to reliably and reproducibly measure corneal thickness. The 
methodologies used in these techniques are based on either 
ultrasonic or optical principles. While each of the methods have 
a peculiarity of their own, all have been described as reliable [6, 
7]. Systematic differences exist between the different techniques 
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Abstract
Purpose: Studies of the cornea, show that corneal thickness is an important factor infl uencing the accuracy of measuring 
intraocular pressure. A pachymetry test is a simple, quick, painless test to measure the thickness of the cornea. With this 
measurement, we can better understand the IOP reading and develop a treatment plan that is right for the condition. 
Several techniques are available to reliably and reproducibly measure corneal thickness. The methodologies used in 
these techniques are based on either ultrasonic or optical principles. While each of the methods have a peculiarity of 
their own, all have been described as reliable.
Material and methods: A retrospective analytical study of the medical records of primary open-angle glaucoma 
patient, that visited the Glaucoma department of the University Eye Clinic between January 2014 and December 2014. 
All subjects underwent a complete eye examination. Central corenal thickness (CCT) measurement and various other 
eye tests were performed, including best-corrected visual acuity (CVA), intraocular pressure (IOP), cup-to-disc ratio 
(C/D), visual fi elds by automated perimetry and RNFL thickness.
Results: Thinner baseline CCT was associated with more advanced damage at presentation, correlated with mean 
deviation (MD) (r=0.17, p=0.02) and neuroretinal rim area (NRR) (r=0.20, p=0.02). Glaucomatous eyes had 
signifi cantly thinner (p=0.01) baseline CCT compared to non-glaucomatous eyes. The slope of visual fi eld change 
was signifi cantly greater (p=0.05) for eyes with thinner (<540 μm) as compared to thicker corneas. A  signifi cant CCT 
reduction (12.78 ± 13.35 μm, p<0.0001) was noted in glaucomatous eyes. CCT change was in correlation with visual 
fi eld MD. A thinner CCT (Odds ratio=1.80, p=0.02), was a signifi cant risk factor for glaucoma.
Conclusion: In our study, CCT correlated signifi cantly with the amount of glaucomatous damage at presentation. 
Thinner corneas may be associated with increased risk of visual fi eld progression. 
Key words: glaucoma, pachimetry, visual fi elds.
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Fig. 1. Cornea pachymetry. 
and result in different values [8]. As a result, the measurements 
cannot simply be substituted between the different modalities.
- Traditional ultrasound (10-20 MHz) 
- Ultrasound biomicroscopy (50 MHz) and very-high-
frequency ultrasound (70 MHz) have the disadvantage of 
requiring a water bath, but allow for determination of corneal 
sublayers details and pachymetry.
- Specular microscope (Topcon Corp.) is a non-contact 
optical instrument that provides pachymetry and specular 
microscopy simultaneously.
- Orbscan is a non-contact optical scanning-slit instrument 
that provides pachymetry in addition to topographic analysis.
- Optical coherence tomography (OCT) non-contact 
techniques that acquire pachymetry measurements based on 
optical interferometry.
- Confocal microscopy is a contact technique that acquires 
measurements by thorough focusing a confocal microscope 
through the thickness of the cornea.
- The Pentacam Scheimpfl ug Camera is a non-contact 
technique that uses a rotating Scheimpfl ug camera to rapidly 
capture images of the anterior segment of the Laser Doppler 
interferometry is a non-contact technique that uses a dual-
beam infrared laser Doppler interferometry to measure corneal 
thickness.
 
Material and methods
A retrospective analytical study of the medical records of 
primary open-angle glaucoma patients, between January 2014 
to December 2014, were reviewed in the Glaucoma Department 
of the University Eye Clinic in Skopje, Macedonia.
All subjects underwent a complete eye examination. Central 
corenal thickness (CCT) measurement and various other eye 
tests were performed, including best-corrected visual acuity 
(CVA), intraocular pressure (IOP), cup-to-disc ratio (C/D), visual 
fi elds by automated perimetry and RNFL thickness by OCT in 
each patient.
The participants underwent a standardized protocol with 
a comprehensive questionnaire; ophthalmic examination (slit-
Fig. 2. Results of cornea pachymetry.
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lamp biomicroscopy; autorefractometry; noncontact tonometry; 
fundus photography; CCT measurements (optical pachymetry); 
visual fi eld testing).  
The gender distribution was 65% male and 35% female. 
The average age was 62.5 years.
The results showed that in 32 patients there were no glau-
comatous visual fi eld defects and they were treated as ocular 
hypertension, while in 18 patients we have found pachymetric, 
visual fi eld and OCT positive signs of glaucoma and they were 
treated with the appropriate therapy.
Discrepancies between tonometry and CCT readings were 
evaluated after stratifi cation into thin, intermediate, and thick 
CCT groups. 
Results
Thinner baseline CCT was associated with more advanced 
damage at presentation, with greater mean deviation (MD) 
depreesion (r=0.17, p=0.02) and larger neuroretinal rim area 
(NRR) (r=0.20, p=0.02).
Glaucomatous eyes had signifi cantly thinner (p=0.01) 
baseline CCT compared to non-glaucomatous eyes.
Fig. 3. Corneal pachymetry of both eyes.
The slope of visual fi eld change over time was signifi cantly 
greater (p=0.05) for eyes with thinner (<540 μm) as compared 
to eyes with thicker corneas.
A  signifi cant CCT reduction (12.78 ± 13.35 μm, p<0.0001) 
was noted in glaucomatous eyes. 
CCT change was correlated with the visual fi eld MD. A 
thinner CCT (Odds ratio=1.80, p=0.02), was a signifi cant risk 
factor for glaucoma.
Discussion
Corneal thickness (along with other parameters) may hold 
signifi cant infl uence on accurate measurement of intraocular 
pressure (IOP). 
In addition, the Ocular Hypertension Treatment Study 
(OHTS), a large-scale longitudinal study, clearly demonstrated 
a thin CCT value as a substantial and independent risk factor 
for the development of primary open-angle glaucoma (POAG).
The reasons for the correaltion between thin CCT and 
POAG development are presently unclea, and there are few 
studies regarding CCT as correlated with POAG risk factors 
such as IOP [9, 10].
Moreover, the defi nitive answer to the question of a causal 
vs. correlative relationship of CCT and POAG remains somewhat 
elusive. The study published in the Am J Ophthalmol [17] may 
help to shed some light on this intriguing feature of glaucoma 
connected with the oxygen levels of the anterior chamber. In 
this cross-sectional study, 124 patients had the oxygen levels 
of their anterior chambers measured directly by means of 
paracentesis and a fi ber optic oxygen sensor at three different 
and distinct locations: just posterior to the central corneal 
endothelium, midway through the anterior chamber, and at the 
anterior chamber angle. The results of the study showed that 
oxygen levels were higher in patients with thinner CCT values. 
However, this result was isolated to the anterior chamber angles 
and not the other ocular sites in these patients.
Such a specifi c correlation is particularly intriguing due 
to the fact that the trabecular meshwork is located within the 
anterior chamber angle and provides some evidence for such 
a scenario. Could it be that oxygen and/or reactive oxygen 
species damage the trabecular meshwork at a molecular level, 
thus affecting its structural, and therefore, functional integrity? 
The authors of the study are among those who suggest this 
very possibility. 
It has been shown that oxidative stress plays a signifi cant 
role in damage to the trabecular meshwork in glaucoma models 
[11, 12].
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Since the trabecular meshwork and the lamina cribosa share 
common developmental origin from the neuro-ectoderm, there 
may be a good reason to believe that oxidative stress would 
damage the lamina cribosa in a similar fashion, thus exposing 
and predisposing the retinal ganglion cells and their axons that 
fenestrate through it to damage and eventual premature cell 
death (which happens in glaucoma).
So, with the potential relationship between CCT values and 
oxidative stress (and the OHTS study) in mind, pachymetry 
values are important and essential to an accurate glaucoma 
work-up and could be considered a tipping point for treatment 
even more than monitoring for change.
Further, the suggested inverse relationship between CCT 
values and oxygen levels in the anterior chamber angle acts 
as another check in the box that we, as clinicians, are truly on 
the verge of being able to treat glaucoma in ways other than 
lowering IOP. 
The potential for these concepts to lead to new horizons 
in glaucoma treatment is exciting, especially in the presence 
of conditions such as normal-tension glaucoma, in which IOP 
increase plays less of a role. 
Thinking about glaucoma variables other than IOP as risk 
factors also helps us, as clinicians, to move beyond the “gold 
standard” of 21 mmHg as an IOP upper normal limit. The future 
of glaucoma therapy is likely to be highly personalized. We will 
likely be able to not only modify variables other than IOP (such 
as oxidative stress), but we will also be able to identify patients 
in which one or more variables matters more than the others. 
This is all still somewhat conceptual, but not off the radar. 
Moreover, with the possible CCT-oxidative stress relationship 
in mind, pachymetry may provide at least a partial insight into 
such concepts [13-16].
Therefore, in the modern age of big and colorful OCT 
printouts that quantify retinal nerve fi ber and ganglion cell layer 
thickness down to just a few microns, it’s surprising that old 
pachymetry test is still so important.
Conclusions 
Pachymetry in relation with visual fi eld examination are im-
portant diagnostic procedures for the right diagnosis and prog-
nosis of newly diagnosed glaucoma patients.
In our study CCT correlated signifi cantly with the amount of 
glaucomatous damage at presentation. Thinner corneas may be 
associated with increased risk of visual fi eld progression. 
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